Evaluation of Serum Leptin and Ferritin Levels in Females with Beta Thalassemia Major
DOI:
https://doi.org/10.22401/Keywords:
Adipokines, Leptin, Iron overload, Splenectomy, Beta thalassemia majorAbstract
Beta thalassemia is an inherited blood disorder caused by inadequate or absence synthesis of β-globin chains. It is classified into three subgroups: β-thalassemia minor, β-thalassemia intermedia, and β-thalassemia major. Beta thalassemia patients suffer from chronic hemolytic anemia and consequently, require frequent blood transfusions, which however can cause iron overload in tissues and organs. The accumulation of iron can cause severe complications such as endocrine dysfunction and chronic liver diseases. Leptin, a polypeptide hormone secreted by adipose tissue and plays an important role in maintaining body weight. This study aimed to evaluate serum leptin and ferritin levels in females with beta thalassemia major. The study included 35 splenectomized thalassemia patients and 35 healthy controls. Anthropometric profile, hematological profile, and serum ferritin and leptin levels were determined for all participants. The results showed a significant decrease in body mass index (BMI), red blood cell (RBC), hemoglobin (Hb), hematocrit (Hct), mean corpuscular volume (MCV), and leptin in thalassemia patients compared to the healthy controls. In contrast, there was a significant increase in serum ferritin in thalassemia patients compared to the healthy controls. It is concluded that patients with beta thalassemia major had considerably lower serum leptin levels. The increased blood ferritin levels in these patients suggest that the malfunction of adipose tissue brought on by iron overload is probably linked to this drop in leptin.
References
[1] Angastiniotis M, Lobitz S.; " Thalassemias: an overview ". Int J Neonatal Screen., 5(1):1-11, 2019.
[2] Wafaa, F. A. M.; " The Beta-Thalassemia ". Sci. J. Med. Res., 1(1):24-30, 2017.
[3] Zhou, X.; Huang, L.; Wu, J.; Qu, Y.; Jiang, H.; Zhang, J.; and Lian, Q.; " Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia ". Biomed Pharmacother., 146(1):112-117, 2022.
[4] Carsote, M.; Vasiliu, C.; Trandafir, A. I.; Albu, S. E., Dumitrascu, M. C.; Popa, A.; and Sandru, F.; " New entity—thalassemic endocrine disease: major beta-thalassemia and endocrine involvement ". Diagnostics., 12(8):1921-1949, 2022.
[5] Kattamis, A.; Forni, G. L.; Aydinok, Y.; and Viprakasit, V.; " Changing patterns in the epidemiology of β-thalassemia ". Eur J Haematol., 105(6):692-703, 2020.
[6] Chuncharunee, S.; Teawtrakul, N.; Siritanaratkul, N.; and Chueamuangphan, N.; " Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand ". PLoS One., 14(3):21-33, 2019.
[7] Al-Bairmani, H. K.; Abdulhameed, Q. M.; and Alfartusie, F. S.; " Estimation of adenosine deaminase in adult iraqi patients with β-thalassemia ". J Glob Pharma Technol., 10(6):393-397, 2019.
[8] Recinella, L.; Orlando, G.; Ferrante, C.; Chiavaroli, A.; Brunetti, L.; and Leone, S.; " Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases ". Front Physiol., 11(1):57-88, 2020.
[9] Clemente-Suárez, V. J.; Redondo-Flórez, L.; Beltrán-Velasco, A. I.; Martín-Rodríguez, A.; Martínez-Guardado, I.; Navarro-Jiménez, E.; and Tornero-Aguilera, J. F.; " The role of adipokines in health and disease ". Biomedicines., 11(5):1290-1330, 2023.
[10] Giralt, M.; Cereijo, R.; and Villarroya, F.; " Adipokines and the endocrine role of adipose tissues ". Metab Control., 164(1): 265-282, 2016.
[11] Gautron L, Elmquist JK. " Sixteen years and counting: an update on leptin in energy balance ". J Clin Invest., 121(6):2087-2093, 2011.
[12] Kara H.; " Leptin, ghrelin, and other peptide hormones: an overview of their structures and functions ". Psychiatry Clin Psychopharmacol., 28(1):323-324, 2018.
[13] Ibraheam, Z. I.; " Correlation between Uric Acid and Liptin with Its Ratio in a Sample of Iraqi Patients with Diabetes Mellitus ", J. Al-Nahrain Uni. Sci. 14(3): 17-23, 2011.
[14] Friedman J.; " Leptin at 20: an overview ". J Endocrinol., 223(1):223-233, 2014.
[15] Friedman JM.; " Leptin and the endocrine control of energy balance ". Nat Metab., 1(8):754-764, 2019.
[16] Fantuzzi G,; Faggioni R.; " Leptin in the regulation of immunity, inflammation, and hematopoiesis ". J Leukoc Biol., 68(4):437-446, 2000.
[17] Manohar, S. M.; Shah, P.; and Nair, A.; " Flow cytometry: Principles, applications and recent advances ". Bioanalysis., 13(3):181-198, 2021.
[18] Yousefian, S.; Mirialiabad, G.; Saleh, R.; and Khedmati, M.; " Association of Body mass index and serum ferritin level in pediatrics with Beta-thalassemia major disease ". Iran J Pediatr Hematol Oncol., 12(1):34-40, 2022.
[19] Al-Naama LM.; Hassan MK.; Abdul Karim MM.; " Evaluation of serum leptin levels and growth in patients with β-thalassaemia major ". Anemia., 84(1):54-60, 2016.
[20] El-Deen, Z. M. M.; Ismail, A. M.; Meguid, M. M. A.; and Harb, M. T.; " Some endocrinal changes in children with β-thalassemia major ". Egypt J Haematol., 39(3):103-108, 2014.
[21] Shah, F. T.; Sayani, F.; Trompeter, S.; Drasar, E.; and Piga, A.; " Challenges of blood transfusions in β-thalassemia ". Blood Rev., 37(1):100-112, 2019.
[22] Rivella, S.; " Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia ". Blood, J Am Soc Hematol., 133(1):51-58, 2019.
[23] Khawaji, M. M.; Hazzazi, A. A.; Ageeli, M. H.; Mawkili, Y. H.; Darbashi, A. H., Kathiyah, A. M. A .A.; and Humedi, R. A.; " Clinical and hematological features among β-thalassemia major patients in Jazan region: A hospital-based study ". J Fam Med Prim care., 9(1):412-417, 2020.
[24] Tari, K.; Valizadeh Ardalan, P.; Abbas zadehdibavar, M.; Atashi, A.; Jalili, A.; and Gheidishahran, M.; " Thalassemia an update: molecular basis, clinical features and treatment ". Int J Biomed public Heal., 1(1):48-58, 2018.
[25] Arab-Zozani, M.; Kheyrandish, S.; Rastgar, A.; and Miri-Moghaddam, E.; " A systematic review and meta-analysis of stature growth complications in β-thalassemia major patients ". Ann Glob Heal., 87(1):1-17, 2021.
[26] Arshad, B.; Iqbal, T.; Jamil, A.; and Asan, I. J. H.; " Hematological and biochemical changes in male patients with thalassemia major ". Pak. j. life soc. Sci., 12(1):31-35, 2014.
[27] Roth, I. L.; Lachover, B.; Koren, G.; Levin, C.; Zalman, L.; and Koren, A.; " Detection of β-thalassemia carriers by red cell parameters obtained from automatic counters using mathematical formulas ". Mediterr J Hematol Infect Dis., 10(1):201-210, 2018.
[28] AlAthari, R.A.; and Mahdi, W.T.; " Investigating Some Of Blood Parameters In Women With β-Thalassemia ". In Journal of Physics: Conference Series., 1294(6):62-69, 2019.
[29] Sumneang, N.; Siri-Angkul, N.; Kumfu, S.; Chattipakorn, S. C.; and Chattipakorn, N., " The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes ". Arch Biochem Biophys., 680(1):108-113, 2020.
[30] Hagag, A. A.; Ebtesam, R.; Maaly, M. M.; and Ibrahim, M. B.; " Study of serum leptin in children with beta thalassemia: Correlation with iron overload ". Med J Cairo Univ., 86(1):3037-3045, 2018.
[31] Ali, S.; Mumtaz, S.; Shakir, H. A.; Khan, M.; Tahir, H. M.; Mumtaz, S.; and Khan, M. A.; " Current status of beta thalassemia and its treatment strategies ". Mol Genet genomic Med., 9(12):1788-1801, 2021.
[32] Harbi, N. S.; Jawad, A. H.; and Alsalman, F. K.; " Evaluation of adipokines concentration in Iraqi patients with major and minor beta thalassemia ". Reports Biochem Mol Biol., 9(2):209-215, 2020.
[33] Al-Fatlawi, A. C. Y.; " Evaluation of leptin serum concentration in cases of blood transfusion dependent beta thalassemia and its relationship with thyroid dysfunction ". Biomedicine., 42(5):1029-1033, 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Fatima A. Abdulhaleem, Alaa Hussein J. Al-Qaisi, Dalia M. Jamil, Amamer M. Redwan, Nur Wahida Zulkifli

This work is licensed under a Creative Commons Attribution 4.0 International License.